122 related articles for article (PubMed ID: 8817674)
1. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGF is a cell growth inhibitor.
Lalou C; Lassarre C; Binoux M
Prog Growth Factor Res; 1995; 6(2-4):311-6. PubMed ID: 8817674
[TBL] [Abstract][Full Text] [Related]
2. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
Lalou C; Lassarre C; Binoux M
Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3.
Lalou C; Lassarre C; Binoux M
Horm Res; 1996; 45(3-5):156-9. PubMed ID: 8964575
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3.
Angelloz-Nicoud P; Lalou C; Binoux M
Growth Horm IGF Res; 1998 Feb; 8(1):71-5. PubMed ID: 10990447
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity.
Lalou C; Sawamura S; Segovia B; Ogawa Y; Binoux M
C R Acad Sci III; 1997 Aug; 320(8):621-8. PubMed ID: 9337997
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
Salahifar H; Baxter RC; Martin JL
Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
[TBL] [Abstract][Full Text] [Related]
7. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene.
Zadeh SM; Binoux M
Endocrinology; 1997 Jul; 138(7):3069-72. PubMed ID: 9202255
[TBL] [Abstract][Full Text] [Related]
8. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
9. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
10. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
Bang P; Brismar K; Rosenfeld RG
J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
[TBL] [Abstract][Full Text] [Related]
11. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine.
Vorwerk P; Yamanaka Y; Spagnoli A; Oh Y; Rosenfeld RG
J Clin Endocrinol Metab; 1998 Apr; 83(4):1392-5. PubMed ID: 9543173
[TBL] [Abstract][Full Text] [Related]
12. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells.
Conover CA; Kiefer MC
J Clin Endocrinol Metab; 1993 May; 76(5):1153-9. PubMed ID: 7684391
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
Angelloz-Nicoud P; Harel L; Binoux M
Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
[TBL] [Abstract][Full Text] [Related]
14. Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: application to the study of the effects of antibodies and heparin.
Koedam JA; Hoogerbrugge CM; van Buul-Offers SC; Van den Brande JL
J Endocrinol; 1997 Apr; 153(1):87-97. PubMed ID: 9135573
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.
Irwin JC; Dsupin BA; Giudice LC
J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715
[TBL] [Abstract][Full Text] [Related]
16. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.
Kanzaki S; Hilliker S; Baylink DJ; Mohan S
Endocrinology; 1994 Jan; 134(1):383-92. PubMed ID: 7506211
[TBL] [Abstract][Full Text] [Related]
17. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments.
Booth BA; Boes M; Bar RS
Am J Physiol; 1996 Sep; 271(3 Pt 1):E465-70. PubMed ID: 8843739
[TBL] [Abstract][Full Text] [Related]
18. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
Angelloz-Nicoud P; Binoux M
Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
[TBL] [Abstract][Full Text] [Related]
19. An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner.
Shahjee H; Bhattacharyya N; Zappala G; Wiench M; Prakash S; Rechler MM
Growth Horm IGF Res; 2008 Jun; 18(3):188-97. PubMed ID: 17959403
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
